2024
DOI: 10.1021/acsnano.3c10213
|View full text |Cite
|
Sign up to set email alerts
|

Multipathway Regulation for Targeted Atherosclerosis Therapy Using Anti-miR-33-Loaded DNA Origami

Yuxuan Ma,
Qi Wang,
Shiyu Du
et al.

Abstract: Given the multifactorial pathogenesis of atherosclerosis (AS), a chronic inflammatory disease, combination therapy arises as a compelling approach to effectively address the complex interplay of pathogenic mechanisms for a more desired treatment outcome. Here, we present cRGD/ASO tDON, a nanoformulation based on a self-assembled DNA origami nanostructure for the targeted combination therapy of AS. cRGD/ASO tDON targets α v β 3 integrin receptors overexpressed on pro-inflammatory macrophages and activated endot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 77 publications
(105 reference statements)
0
0
0
Order By: Relevance
“…DNA origami has emerged as a promising nanocarrier for targeted disease treatment, efficiently enhancing the therapeutic outcomes of various drugs. In particular, its ability to exhibit preferential renal uptake renders DNA origami a promising delivery platform for the treatment of renal diseases. ,, Flat DNA origami, such as rectangular DNA origami, can precisely manipulate biomolecules on their surface due to their sub-10 nm addressability. Thus, many proteins, including IL-10, can be effectively loaded onto the DNA origami surface. Furthermore, DNA origami exhibits remarkable sensitivity to various ROS, positioning it as a potential scavenger for effectively eliminating ROS. ,, In addition to its excellent biocompatibility, biodegradability, and low immunogenicity, DNA origami can serve as a functional and renal-targeting delivery platform.…”
Section: Introductionmentioning
confidence: 99%
“…DNA origami has emerged as a promising nanocarrier for targeted disease treatment, efficiently enhancing the therapeutic outcomes of various drugs. In particular, its ability to exhibit preferential renal uptake renders DNA origami a promising delivery platform for the treatment of renal diseases. ,, Flat DNA origami, such as rectangular DNA origami, can precisely manipulate biomolecules on their surface due to their sub-10 nm addressability. Thus, many proteins, including IL-10, can be effectively loaded onto the DNA origami surface. Furthermore, DNA origami exhibits remarkable sensitivity to various ROS, positioning it as a potential scavenger for effectively eliminating ROS. ,, In addition to its excellent biocompatibility, biodegradability, and low immunogenicity, DNA origami can serve as a functional and renal-targeting delivery platform.…”
Section: Introductionmentioning
confidence: 99%